How has Boston Scientific's equity method investments (note 11) changed year-over-year?

Boston Scientific's equity method investments (note 11) decreased by 13.7% year-over-year, from $358M to $309M.

What is the long-term trend for Boston Scientific's equity method investments (note 11)?

Over 5 years (2020 to 2025), Boston Scientific's equity method investments (note 11) has grown at a 4.4% compound annual growth rate (CAGR), from $319M to $396M.

Boston Scientific BSX Equity method investments (Note 11)

Equity method investments (Note 11) at other companies

AbbottABT

——

Edwards LifesciencesEW

——

MedtronicMDT

——

ResMedRMD

——

ROP

Roper Technologies, Inc.ROP

——

Other financials

Income statement

See full

Revenue$5.2B+11.6%

Gross profit$3.6B+12.6%

Operating income$1.1B+19.5%

Net income$1.3B+99.3%

EPS (diluted)$0.90+100%

Balance sheet

See full

Cash & equivalents$850.0M+146%

Total equity$25.9B+16.4%

Total assets$44.4B+10.5%

Cash flow

See full

Operating cash flow$348.0M-35.7%

CapEx$177.0M-5.4%

Free cash flow$171.0M-51.7%

Valuation

See full

Market cap$66.81B-37.5%

P/E18.8×-34.0×

P/S3.2×-2.8×

Profitability

See full

Gross margin69.2%+0.5pp

Operating margin18.4%+2.2pp

Net margin17.3%+5.7pp

Returns & leverage

See full

Return on equity14.8%+5.2pp

Debt / equity0×-0.5×

Current ratio1.9×+0.4×

Where this comes from

Reported directly by Boston Scientific in its filing.

Tagged under the XBRL concept us-gaap:EquityMethodInvestments.

The official record: Boston Scientific’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Boston Scientific's equity method investments (note 11).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Boston Scientific's equity method investments (note 11)?: Boston Scientific (BSX) reported equity method investments (note 11) of $309M in Q1 2026.
How has Boston Scientific's equity method investments (note 11) changed year-over-year?: Boston Scientific's equity method investments (note 11) decreased by 13.7% year-over-year, from $358M to $309M.
What is the long-term trend for Boston Scientific's equity method investments (note 11)?: Over 5 years (2020 to 2025), Boston Scientific's equity method investments (note 11) has grown at a 4.4% compound annual growth rate (CAGR), from $319M to $396M.